Variational AI has entered a partnership with Merck to utilize its Enki™ platform in discovering novel small molecule therapeutics. This collaboration will focus on two undisclosed targets identified by Merck, under an agreement which includes an upfront payment and milestones potentially worth up to $349 million.
Company Information
Company
Variational AI
Location
Vancouver, British Columbia, Canada
About
Variational AI has developed Enki, the biopharma industry's first commercially-available foundation model for small molecules. Enki is based on a novel generative AI framework invented by Variational AI that has delivered novel and selective leads to multiple biopharma partners and customers.
VancouverBiotechnologyArtificial IntelligenceMachine Learning